作者: Jason Marc Foulks , David Lee Vollmer , Koc-Kan Ho , Jihua Liu , Yong Xu
DOI:
关键词:
摘要: Compounds having activity as PKM2 activators are disclosed. The compounds have the following structure (I): including stereoisomers, tautomers, pharmaceutically acceptable salts and prodrugs thereof, wherein R1, R2, R3, R4, R5 R6 defined herein. Methods associated with preparation use of such compounds, well pharmaceutical compositions comprising also